Bailard
DGX icon

Bailard’s Quest Diagnostics DGX Stock Holding History

Bailard’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.4M Buy
6,016
+335
+6% +$77.4K 0.03% 294
2026
Q2 		$1.2M Buy
5,681
+136
+2% +$26.7K 0.02% 319
2026
Q1 		$1.09M Buy
5,545
+1,499
+37% +$291K 0.03% 313
2025
Q4 		$702K Buy
+4,046
New +$737K 0.02% 401
2021
Q2 		– Sell
-2,668
Closed -$342K – 716
2021
Q1 		$342K Sell
2,668
-37,868
-93% -$4.67M 0.01% 472
2020
Q4 		$4.83M Buy
40,536
+378
+0.9% +$46.1K 0.22% 93
2020
Q3 		$4.6M Buy
40,158
+867
+2% +$102K 0.24% 84
2020
Q2 		$4.48M Buy
39,291
+3,995
+11% +$424K 0.25% 83
2020
Q1 		$2.83M Buy
35,296
+5,502
+18% +$570K 0.2% 100
2019
Q4 		$3.18M Buy
29,794
+7,520
+34% +$784K 0.18% 114
2019
Q3 		$2.38M Buy
22,274
+1,709
+8% +$175K 0.14% 139
2019
Q2 		$2.09M Buy
20,565
+882
+4% +$84.8K 0.13% 155
2019
Q1 		$1.77M Sell
19,683
-68
-0.3% -$5.89K 0.11% 165
2018
Q4 		$1.64M Sell
19,751
-14,664
-43% -$1.37M 0.11% 162
2018
Q3 		$3.71M Sell
34,415
-476
-1% -$52.2K 0.22% 101
2018
Q2 		$3.84M Buy
+34,891
New +$3.63M 0.23% 99

Other funds holding DGX

Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Willis Investment Counsel
Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Boston Common Asset Management
Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
JGP Wealth Management
JGP Wealth Management Bend, Oregon $1.13B AUM 26% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Bailard's DGX Position: Q3 2026 in Review

Bailard increased its Quest Diagnostics (DGX) stake by 5.9% in Q3 2026, buying an estimated $77.4K and bringing the position to 6,016 shares worth $1.4M. The position accounts for 0.03% of the portfolio, ranked #294.

Bailard first reported a position in DGX in Q2 2018 and has held it in 16 quarters since. The position peaked at $4.83M in Q4 2020. 192 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Bailard held 6,016 shares of Quest Diagnostics worth $1.4M as of Q3 2026.
  • Bailard bought 335 Quest Diagnostics shares in Q3 2026, an estimated $77.4K.
  • Quest Diagnostics made up 0.03% of Bailard's portfolio in Q3 2026, its #294 holding.
  • Bailard first reported a position in Quest Diagnostics in Q2 2018 and has held it in 16 quarters since.
  • Bailard's Quest Diagnostics position peaked at $4.83M in Q4 2020.
  • 192 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.